Brief: SeaStar Medical Q1 EPS USD -0.9
13/05/2026 21:05
May 13 (Reuters) - SeaStar Medical Q1 operating expenses USD 4.052 million. Q1 operating income USD -3.603 million Q1 net income USD -3.521 million
Recent news on SeaStar Medical Holding
See all newsSeaStar Medical Q1 revenue rises on QUELIMMUNE growth
Brief: SeaStar Medical Q1 EPS USD -0.9
Brief: Seastar Medical Holding Corp - Prospectus Relates To Resale, From Time To Time, Of Up To 2 Million Shares Of Our Common Stock By Selling Stockholder
SeaStar Medical's Q4 revenue rises, net loss narrows
Brief: Seastar Medical Announces Completion Of FDA Enrollment Requirement For Save Surveillance Registry Evaluating Quelimmune Safety For Pediatric Aki